Investing.com - Merck reported on Friday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Merck announced earnings per share of €2.64 on revenue of €5.57B. Analysts polled by Investing.com anticipated EPS of €2.51 on revenue of €5.42B.
Merck shares are down 26.38% from the beginning of the year , still down 25.39% from its 52 week high of €231.47 set on Wednesday, December 29, 2021. They are under-performing the EUR/USD which is down 0% year to date.
Merck follows other major Healthcare sector earnings this month
Merck's report follows an earnings beat by Elekta B on Thursday, August 25, 2022, who reported EPS of €0.16 on revenue of €3.33B, compared to forecasts EPS of €0.1585 on revenue of €3.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar